Profile
Robert Paul formerly worked at Nine Square Therapeutics, Inc., as Chief Executive Officer from 2022 to 2025, Genentech, Inc., as Assistant Director-Group Medical from 2015 to 2016, and Alector, Inc., as Chief Medical Officer from 2016 to 2021.
Dr. Paul received his doctorate degree from Ludwig-Maximilians-Universität München.
Former positions of Robert Paul
| Companies | Position | End |
|---|---|---|
Nine Square Therapeutics, Inc.
Nine Square Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Chief Executive Officer | 01/02/2025 |
| ALECTOR, INC. | Chief Tech/Sci/R&D Officer | 11/10/2021 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/10/2016 |
Training of Robert Paul
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alector, Inc.
Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
Nine Square Therapeutics, Inc.
Nine Square Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
- Stock Market
- Insiders
- Robert Paul
















